This review summarises the current understanding of immune response and T cell subsets
in the context of development of autoimmunity in the dog. Mode of action and rational usage …

Immune-mediated hemolytic anemia (IMHA) is a common type of anemia in dogs and cats
that results from a type II hypersensitivity reaction. The disease is most common in middle …

Immune‐mediated hemolytic anemia (IMHA) is an important cause of morbidity and mortality
in dogs. IMHA also occurs in cats, although less commonly. IMHA is considered secondary …

Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is
associated with considerable morbidity and mortality. Treatment with various …

Objective—To evaluate prognostic factors, survival, and treatment protocols for immune-
mediated hemolytic anemia (IMHA) in dogs. Design—Retrospective study. Animals—151 …

Breed Predispositions to Disease in Dogs and Cats, Third Edition provides a comprehensive
exploration of current knowledge of breed predispositions based on rigorous examination of …

Companion animal practice is an ever-changing field. As new research and experience
broaden our knowledge, changes in practice, treatment, and drug therapy may become …

Histiocytic disorders of dogs include histiocytoma, localized histiocytic sarcoma (HS),
disseminated HS (malignant histocytosis), and the reactive histiocytoses: cutaneous and …

Background: Canine idiopathic immune‐mediated hemolytic anemia (IMHA) is associated
with a high mortality, especially in the 1st 2 weeks after diagnosis despite treatment …

Background Portal vein thrombosis (PVT) has been reported infrequently in dogs. Objectives
To characterize the presentation, associated disease conditions, and outcome in dogs with …